Transparency Council on endometriosis, among other things

The agenda includes:

1. Preparation of a position paper on the evaluation of the drug Ryeqo(relugolixum + estradiolum + norethisterone acetate) for the indication: symptomatic treatment of endometriosis in adult women of childbearing age who have previously received pharmacological or surgical treatment.
2. Preparation of a position paper on examining the appropriateness of issuing reimbursement approvals for the medicinal product Arginine 2000 AA Supplement for the indications:
   
   • Ornithine transcarbamylase deficit (OTC deficit),
   • lysinuric protein intolerance,
   • creatine deficiency syndrome.

3. Prepare an opinion on the draft health policy program of the local government unit:
"Comprehensive rehabilitation of a child with disabilities from the municipality of Godow".

4. Prepare an opinion on the draft health policy program of the local government unit:
"Health policy program on prevention of depressive disorders in children and adolescents of the Mazovian province".

5. Prepare an opinion on the draft health policy program of the local government unit:
"Regional Health Program on expanding the availability of modern instrumental methods of diagnosis and rehabilitation of children with cerebral palsy in the territory of the Mazovian province."

6. preparation of an opinion on the legitimacy of continuation of reimbursement in off-label indications for the active substance etanerceptum in the indication: treatment of peripheral form of SpA under the drug program B.82.

Source: AOTMiT